Why Is Hyatt Hotels Stock Sliding Today?

Hyatt Hotels reports Q1 sales growth of 2%, surpassing analyst estimates. Comparable RevPAR rises by 5.5%, reflecting strong performance. Adjusted EBITDA dips by 5.9% to $252 million, while adjusted EPS falls short at $0.71.

Hyatt Hotels Corporation (NYSE:H) shares are trading lower after the company reported first-quarter adjusted EPS below street view.

The company reported first-quarter FY24 sales growth of 2% year-on-year to $1.714 billion, beating the analyst consensus estimate of $1.707 billion.

Comparable system-wide RevPAR increased 5.5% to $131.86. System-wide Net Rooms Growth was 5.5%. Comparable owned and leased hotels RevPAR increased 0.1% to $178.04.

Adjusted EBITDA fell 5.9% to $252 million from $268 million last year. Adjusted EPS of $0.71 missed the analyst consensus of $0.91.

Hyatt repurchased 528,427 million shares of Class A common stock for $76 million in the first quarter. The company held $794 million in cash and equivalents as of March-end. At the end of first-quarter, the company had a total debt of $3.05 billion.

The company’s board of directors has authorized the repurchase of up to an additional $1 billion of the company’s common stock. As of May 9, the company has approximately $1.8 billion remaining under the share repurchase authorization.

Outlook: Hyatt expects FY24 capital expenditure to be $170 million. The company currently expects to grow net rooms by 5.5% – 6%. It expects comparable system-wide hotels RevPAR to increase 3% to 5% on a constant currency basis.

The company’s full-year Adjusted EBITDA is projected between $1.15 billion and $1.19 billion and is in line with the previously provided outlook when adjusting for $30 million of reduced Adjusted EBITDA due to transactions.

Price Action: H shares are trading lower by 1.62% at $145.43 at the last check Thursday.

Photo via Wikimedia Commons

Total
0
Shares
Related Posts
Read More

Pervasip Reports Slight YoY Decrease In Q1 Revenue As It Prepares For Cannabis Spin-Off

Pervasip announced on Tuesday its 2024 first-quarter financial results. Simultaneously, the Seattle, Washington-based company said it's still in the restructuring process and preparation for the spin-out of all of its cannabis assets. "We are entering our final phase of restructuring which involves making difficult decisions to ensure additional expense reductions and separating the company from assets it has held for many years," German Burtscher, Pervasip's president and chief executive officer, said. Additionally, as part of the restructuring, George Jordan has resigned from his duties as CFO and COO of the company and will stay on as an advisor, supporting management through its final phase of changes in preparation for the spin-out of Artizen Corporation.

PVSP